Protalix (PLX) Receives FDA Fast Track Designation for prGCD
Tweet Send to a Friend
Protalix BioTherapeutics, Inc. (NYSE: PLX), announced that it has received Fast Track Designation from the U.S ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
